» Articles » PMID: 25576461

Survey of Patients' Experiences and Their Certainty of Suspected Adverse Drug Reactions

Overview
Publisher Springer
Specialties Pharmacology
Pharmacy
Date 2015 Jan 11
PMID 25576461
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients are best placed to recognize and monitor their own experiences of adverse drug reactions (ADRs), however they may need medicines information to help them do so. In Thailand patients rarely receive information leaflets, but are permitted to report ADRs directly to the regulator.

Objectives: To determine frequency of ADRs reported by hospital out-patients, the information sources used to evaluate suspected ADRs and patients' confidence in ADR identification.

Setting: Srinagarind hospital in Khon Kaen, the second-largest province of North-eastern Thailand.

Methods: A questionnaire designed for self-completion and distributed to out-patients at this tertiary hospital using systematic random sampling over a 2-month period.

Main Outcome Measures: Frequency of reported ADRs, information sources confirming ADRs and degree of confidence in ADR identification.

Results: Of 1,195 questionnaires distributed, 1,044 usable responses were obtained (87.4 %). The majority of respondents were female (57.1 %) with average age 39.6 ± 13.6 years. Of 1,044 valid questionnaires, 257 (24.7 %) patients indicated they had experienced an ADR with high (56.0 %) and moderate (31.9 %) degree of confidence in ADR identification. The most frequent causative agent was an anti-infective (19.1 % of the patients). Major sources of information used for ADR assessment were healthcare professionals (35.5 %) and past ADR experience (25.5 %), with information leaflets being used infrequently (14.6 %).

Conclusions: This study showed high frequency of ADRs among Thai patients who were mostly confident about casual relationships with medicines. Patients mostly used healthcare professionals as confirmation source to evaluate suspected ADRs. Reliable medicines information sources such as information leaflets should be made more widely available.

Citing Articles

Knowledge, Attitude, and Practice Regarding Pharmacovigilance and Barriers to Reporting Adverse Drug Reactions Among the General Population in Saudi Arabia.

Alshehri H, Alharbi A, Alqethami N, Alnuhait M, AlShammari A, Alotaibi A Risk Manag Healthc Policy. 2024; 17:2557-2572.

PMID: 39493376 PMC: 11531241. DOI: 10.2147/RMHP.S484223.


Patients' Identification, Management and Prevention of Adverse Drug Reactions: A Cross-Sectional Survey of Patients with Severe Adverse Drug Reactions.

Srisuriyachanchai W, Cox A, Jarernsiripornkul N J Clin Med. 2024; 13(14).

PMID: 39064204 PMC: 11277768. DOI: 10.3390/jcm13144165.


Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs.

Jarernsiripornkul N, Tiamkao S, Wongtaweepkij K, Jorns T, Junsuaydee K, Nontasen N Int J Clin Pharm. 2023; 46(1):101-110.

PMID: 37843693 DOI: 10.1007/s11096-023-01653-2.


Jordanians' knowledge, attitude and practice regarding adverse drug reactions reporting.

El-Dahiyat F, Hammour K, Farha R, Manaseer Q, Al Momanee A, Allan A Saudi Pharm J. 2023; 31(7):1197-1201.

PMID: 37273263 PMC: 10236368. DOI: 10.1016/j.jsps.2023.05.016.


Awareness, Actions, and Predictors of Actions on Adverse Drug Reaction Reporting among Patients Attending a Referral Hospital in Southern Highland Tanzania.

Sirili N, Kilonzi M, Mwakawanga D, Mohamedi J, Thobias J, Clement A Adv Pharmacol Pharm Sci. 2023; 2023:7761649.

PMID: 37200768 PMC: 10188260. DOI: 10.1155/2023/7761649.


References
1.
Davies E, Green C, Taylor S, Williamson P, Mottram D, Pirmohamed M . Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009; 4(2):e4439. PMC: 2635959. DOI: 10.1371/journal.pone.0004439. View

2.
Jarernsiripornkul N, Senacom P, Uchaipichat V, Chaipichit N, Krska J . Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy. Epilepsy Behav. 2012; 24(1):102-6. DOI: 10.1016/j.yebeh.2012.03.023. View

3.
Miller G, Britth H, Valenti L . Adverse drug events in general practice patients in Australia. Med J Aust. 2006; 184(7):321-4. DOI: 10.5694/j.1326-5377.2006.tb00263.x. View

4.
Jarernsiripornkul N, Chaisrisawadsuk S, Chaiyakum A, Krska J . Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand. Pharm World Sci. 2009; 31(5):559-564. DOI: 10.1007/s11096-009-9310-3. View

5.
de Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K . Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf. 2008; 31(6):515-24. DOI: 10.2165/00002018-200831060-00006. View